Tag Archives: The Stem Cell Blog

Scrambled DNA inside tumours might hinder cancer immunotherapy – Cancer Research UK

Continue reading

2017-01-20 NEWS

Invest Daily News: Market Research News by Market.Biz (press release)

Scrambled DNA inside tumours might hinder cancer immunotherapy
Cancer Research UK
By studying large sets of genetic data the researchers at Harvard Medical School have now uncovered a potential link between how well patients respond to immunotherapy and errors in how the DNA inside their tumour cells is packaged. DNA, genetic …
Cancer Immunotherapy Market will generate new growth …Medgadget (blog)
Non-Specific Cancer Immunotherapy Drug Sales Industry – Market Outlook – Latest Development and Market TrendsSatellite PR News (press release)
Jumbled chromosomes may dampen the immune response to …Science Daily
Invest Daily News: Market Research News by Market.Biz (press release) –Military Technologies
all 14 news articles »
Continue reading

2017-01-20 NEWS

Business Standard

BSE IPO disclosures incomplete, says investor body
Business Standard
“Resultantly, their estimated investment of over rupees one lakh crore has been blocked and is in suspended animation for years. The number of affected small investors may be one crore. They have lost heavily and withdrawn from the securities market, …

Continue reading

2017-01-20 NEWS

Financial Times

Bristol-Myers Squibb, Where Art Thou? Not in First-Line Lung Cancer Immunotherapy, Sadly
TheStreet.com
Bristol-Myers Squibb (BMY) suffered another cancer immunotherapy setback Thursday night when the pharma giant said it would not seek accelerated approval for a combination of two drugs — Opdivo and Yervoy — as a treatment for newly diagnosed lung …
Bristol-Myers shares slide on immunotherapy setbackFinancial Times
Bristol-Myers Dives On Opdivo Setback, Will Get Keytruda RoyaltiesInvestor’s Business Daily
Bristol won’t seek faster Opdivo/Yervoy lung cancer approvalReuters
Business Insider
all 217 news articles »
Continue reading

2017-01-20 NEWS

BioPharma-Reporter.com

Cell preservation prosperity: BioLife and Cryoport up on personalised meds
BioPharma-Reporter.com
… which offers media and logistics services for cell-based therapy developers, boasted preliminary 2016 media sales of $8.2m, up 28% on the previous year. “BioLife’s proprietary, clinical grade biopreservation media products, CryoStor and

Continue reading

2017-01-20 NEWS

Donald Trump Has Plans To Hit The Ground Running
WUWM
But the White House is kind of in a state of suspended animation this morning as we wait for this passing of the baton. There’s a corridor outside the Oval Office that is usually hung with oversized photographs of the president and first family. Those

and more »

Continue reading

2017-01-20 NEWS

Examining The Economy That President-Elect Trump Is Inheriting
WOSU
MARTIN: OK. NPR’s Scott Horsley reporting there from the White House, a place in suspended animation, as you have put it as we await the next president of the United States. Donald Trump will be sworn in as the 45th president. You can stay with us for